Social Media Ideas for Arx:ca

Arcus: 'Buy' On Casdatifan Late-Stage CcRCC Advancement And 1st-Line Expansions

argenx SE (ARGX) Forte Biosciences, Inc. - M&A Call - Slideshow

TRX Gold Corporation (TRX:CA) Q3 2026 Earnings Call Transcript

Shell: ARC Acquisition Shows The Flexibility When Responding To The Middle East Situation

Archer Limited (ARHVF) Q2 2026 Earnings Call Prepared Remarks Transcript

Amarc Announces CAD$20 Million Private Placement Financing

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

What This $1.1 Million Insider Sale at Accelerant Means for Investors

Executed under a pre-arranged Rule 10b5-1 plan, the transaction reduces Radke's stake by just 0.28%, leaving him with ~28.6 million shares worth $379 million.

RTX Corporation: Backlog Boom Meets Cash Flow Inflection

Array Technologies, Inc. (ARRY) Affordable Wire Management, LLC, - M&A Call - Slideshow

argenx: Upgrading To Buy, The VYVGART Growth Cycle Has Further To Go

Barrick Mining Corporation (ABX:CA) Q2 2026 Earnings Call Transcript

ARS Pharma: New CEO's Program Of Reducing Costs While Increasing Revenues Makes A Buy

AAK AB (publ.) 2026 Q2 - Results - Earnings Call Presentation

NexGold Mining: A Strong Junior Gold Developer With Likely Upside

Mining Americas: Gold Producer With Promising Near-Term Development Projects

Antero Resources Corporation (AR) Q2 2026 Earnings Call Transcript

<![CDATA[argenx Acquires Forte Biosciences for $2.2 Billion]]>

Arcani’s Acoustic Sensor Featured on General Dynamics New LAV SPH

ARCANI’s HARK Acoustic Sensor Featured on General Dynamics Land Systems–Canada’s Grizzly LAV Self-Propelled Howitzer (SPH) Platform to Enhance Counter-Drone Situational Awareness [...

Arcos Dorados Holdings Inc. 2026 Q2 - Results - Earnings Call Presentation

Ardelyx Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Ardelyx (ARDX)

ARDX closed at $4.00 on August 7, 2026 -- down 17.86% -- after Q2 product revenue of $118.1 million came in below consensus and analysts cut price targets in accord.

Arteris: Consolidating For The Next Breakout On The Upside

Arrowhead Pharmaceuticals, Inc. (ARWR) Q3 2026 Earnings Call Transcript

RXO: Expectations Seem Imaginary As Core Metrics Worsen In Q2

RXO, Inc. (RXO) Presents at Deutsche Bank's Chicago Industrials Summit Transcript